Woman, 35, dies from brain blood clot caused by AstraZeneca vaccination

Woman, 35, dies from brain blood clot caused by AstraZeneca vaccination

On Monday, Ontario reported the first death in the province associated with a rare blood clotting disorder linked to the AstraZeneca COVID-19 vaccine.

This marks the first death in Ontario related to a potential side effect of the AstraZeneca COVID-19 vaccine called Vaccine-Induced Thrombotic Thrombocytopenia or VITT.

Data from the United Kingdom suggests a much-reduced risk of VITT in second doses of AstraZeneca.

According to the guidelines issued May 21, individuals who previously had blood clots with low blood platelets (thrombosis with thrombocytopenia syndrome, TTS) after Vaxzevria must not be given a second dose of Vaxzevria.

A British woman passed away on the weekend while she was receiving thrombolytic therapy in Cyprus, following her vaccination against COVID earlier this month, with officials admitting a link but unable to pinpoint what exactly may have caused the blood clot.

In this case, everyone working for the clinic that day already had their first shot, so second doses were administered.

The province has said those who got their first dose of AstraZeneca after March 19 will be able to book their second in the near future, but no additional details have been provided so far. "We have not heard of people dying because they did not get the second dose", he said.

"Across the sea in the United Kingdom in order to tackle this concern, they have dropped their time from 12 weeks to eight weeks for the second dose of AstraZeneca", he said.

It is great to see so much excitement because it means that people really want that second dose as soon as they quality for it.

Dr. David Williams, Ontario's chief medical officer of health, has said the shorter interval is safe and provides strong protection against COVID-19.

The second shots are being moved up by about 2 weeks and being given at the 10 week mark rather than the recommended 12 weeks as the province rushes to use a stockpile of 45,000 doses set to expire in roughly a week.

Speaking with CP24 on Tuesday afternoon, Jones said that the province does have "sufficient supply" but will be distributing the vaccine to fewer pharmacies than it did during March's pilot project as part of a "cluster" approach.

"One of the real difficulties they've had is constant changes in the rollout programme that makes it hard for them, particularly with regards to the AstraZeneca vaccine because we know that is the one that's been most variable in terms of delivery".

Bates says pharmacists will reach out to eligible patients who can then start booking appointments as early as Wednesday and Thursday.

"The good point is that we have lots of people wanting to get their second dose", said Williams.

Related Articles